The NEONAX study

Affiliations

¹ Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Baden-Württemberg, Germany.
² Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Baden-Württemberg, Germany. Electronic address: john.neoptolemos@med.uni-heidelberg.de.

Free article

Comment

M W Büchler et al. Ann Oncol. 2023 Apr.

Free article

. 2023 Apr;34(4):442-443.

doi: 10.1016/j.annonc.2023.01.003. Epub 2023 Jan 19.

¹ Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Baden-Württemberg, Germany.
² Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Baden-Württemberg, Germany. Electronic address: john.neoptolemos@med.uni-heidelberg.de.

No abstract available

Conflict of interest statement

Disclosure None declared.

Reply to the Letter to the Editor 'The Neonax study' by M. W. Büchler and J. Neoptolemos.
Seufferlein T, Uhl W, Ettrich TJ; NEONAX study group. Seufferlein T, et al. Ann Oncol. 2023 Apr;34(4):443-445. doi: 10.1016/j.annonc.2023.01.005. Ann Oncol. 2023. PMID: 37061251 No abstract available.

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.
Seufferlein T, Uhl W, Kornmann M, Algül H, Friess H, König A, Ghadimi M, Gallmeier E, Bartsch DK, Lutz MP, Metzger R, Wille K, Gerdes B, Schimanski CC, Graupe F, Kunzmann V, Klein I, Geissler M, Staib L, Waldschmidt D, Bruns C, Wittel U, Fichtner-Feigl S, Daum S, Hinke A, Blome L, Tannapfel A, Kleger A, Berger AW, Kestler AMR, Schuhbaur JS, Perkhofer L, Tempero M, Reinacher-Schick AC, Ettrich TJ. Seufferlein T, et al. Ann Oncol. 2023 Jan;34(1):91-100. doi: 10.1016/j.annonc.2022.09.161. Epub 2022 Oct 7. Ann Oncol. 2023. PMID: 36209981 Clinical Trial.